Operating Company Healthcare

Versiti

Milwaukee, Wisconsin, United States

Nonprofit blood health organization providing blood collection and transfusion medicine, diagnostics, laboratory and clinical trials services, as well as tissue and transplantation services.

Focus Areas
Blood bank / community blood center, Blood donation services, Transfusion medicine
Website
versiti.org

Tracked deals

4

4 tracked deals across 2022-2024.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

4 buyout

Versiti Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Versiti. 1 2022 2 2023 1 2024

Supporting Data

Recent Transactions

  • Buyer
    Versiti Blood Center of Ohio (Versiti)
    Target
    Solvita Blood Center (formerly Community Blood Center)
    Seller
    Solvita
    Type
    Buyout

    Versiti Blood Center of Ohio has acquired Solvita Blood Center (formerly Community Blood Center) to expand Versiti's footprint and blood donation services in the Dayton, Ohio region. The transaction transfers Solvita's blood center operations to Versiti while Solvita retains its global tissue services.

  • Buyer
    Versiti
    Target
    Pearl Pathways
    Type
    Buyout

    Versiti, a Milwaukee-based blood health organization, has acquired Pearl Pathways, an Indianapolis-area life science consulting firm that provides regulatory affairs, quality compliance, CRO services and an independent IRB. The acquisition expands Versiti's clinical trial and life-sciences service capabilities, enabling earlier and deeper support for product development across biopharmaceutical, medical device, and diagnostics clients.

  • Buyer
    Versiti
    Target
    Quantigen
    Type
    Buyout

    Versiti, a national blood health organization headquartered in Milwaukee, has acquired Quantigen, a specialty laboratory and contract research organization based in Fishers, Indiana. The acquisition expands Versiti’s clinical-trials and diagnostic capabilities—adding assay development, biomarker validation, and regulatory support for preclinical and clinical research.

  • Buyer
    Versiti
    Target
    Ethical and Independent Review Services
    Type
    Buyout

    Versiti, a national blood health organization headquartered in Milwaukee, has acquired Missouri-based Ethical and Independent Review Services (E&I), an AAHRPP-accredited independent IRB. The acquisition expands Versiti's clinical trial services and regulatory review capabilities across biopharmaceutical, medical device, and social/behavioral research markets.

Related Acquisition Pages

Selling a company? Get in front of buyers like Versiti

Turn tracked acquisition activity into an outreach-ready buyer list.